PT-141 10mg (10 Vials)

PT-141 Research Peptide

PT-141 (Bremelanotide) is a synthetic peptide studied in laboratory and preclinical models for its interaction with melanocortin receptor pathways and neuropeptide signaling mechanisms. In published research, PT-141 has been investigated for its role in receptor-mediated signaling, peptide–receptor interactions, and central nervous system communication processes within controlled experimental environments.

Researchers commonly explore PT-141 in studies involving melanocortin receptor signaling, neuropeptide pathway activity, and cellular communication networks. Ongoing laboratory research continues to evaluate PT-141 within controlled models examining receptor binding activity, signal transduction pathways, and downstream cellular responses.

PT-141 remains a widely studied peptide in research environments analyzing melanocortin receptor activity and neuropeptide signaling pathways.

Research Areas of Interest

• Melanocortin receptor signaling pathway research
• Neuropeptide signaling and receptor interaction studies
• Cellular communication and signal transduction models
• Peptide–receptor binding analysis
• Molecular pathway investigation in controlled laboratory settings

Product Highlights

• Research Use Only (RUO)
• COA included (batch / lot documentation)
• High-purity peptide material (verified via COA)
• Lyophilized for stability and long-term storage
• Designed for laboratory, analytical, and scientific research use

Related Research Products

Researchers exploring PT-141 may also be interested in:

• Melanotan II Research Peptide
• Melanotan I Research Peptide

This kit includes ten 10mg vials, supporting batch consistency across multiple experiments and extended research protocols.

Research Use Only. Not for human consumption, therapeutic, or diagnostic use.